Company Analysis
Sign in

Atossa Therapeutics, Inc. (ATOS)

Nasdaq: ATOS · Pharmaceutical Preparations · Seattle, WA · filing with the SEC since 2010
Full chart Alerts Compare
Grade4.9
◀ Past 4.4● Present 5.6▶ Future 4.5
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

10 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Atossa Therapeutics, Inc.’s names, not what it holds today.

Patents granted
10
10 utility, 1976 to Dec 31, 2025
Granted in 2025
4
Against 1 in 2024 and 2 in 2023
Applications published
41
7 of them in 2025
Names they are printed under
4
its own name, a former name
By yearGrantedApplications published
'12'13'14'15'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals8
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Atossa Therapeutics, Inc. its own name
named as the applicant on its applications, in US
0 granted
19 published
Atossa Therapeutics, Inc. its own name
US, as the owner printed on each patent
8 granted
6 published
ATOSSA GENETICS INC. a former name
US, as the owner printed on each patent
2 granted
10 published
Atossa Genetics, Inc. a former name
named as the applicant on its applications, in US
0 granted
6 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 25, 202512,479,790Methods for making and using endoxifenPharmaceuticalsAtossa Therapeutics, Inc.
Apr 22, 202512,281,056Methods for making and using endoxifenPharmaceuticalsAtossa Therapeutics, Inc.
Apr 15, 202512,275,684Methods for making and using endoxifenPharmaceuticalsAtossa Therapeutics, Inc.
Jan 21, 202512,201,591Sustained release compositions of endoxifenPharmaceuticalsAtossa Therapeutics, Inc.
Aug 27, 202412,071,391Methods for making and using endoxifenPharmaceuticalsAtossa Therapeutics, Inc.
Jun 20, 202311,680,036Methods for making and using endoxifenPharmaceuticalsAtossa Therapeutics, Inc.
Feb 7, 202311,572,334Methods for making and using endoxifenPharmaceuticalsAtossa Therapeutics, Inc.
Mar 1, 202211,261,151Methods for making and using endoxifenPharmaceuticalsAtossa Therapeutics, Inc.
Jun 9, 20159,052,318Absorbent paper and use thereof for breast cancer detectionAnalysis of biological materialsATOSSA GENETICS INC.
Mar 13, 20128,133,737Systems and methods for breast cancer detection and risk assessmentAnalysis of biological materialsATOSSA GENETICS INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Sep 11, 20252025/0282710METHODS FOR MAKING AND USING ENDOXIFENPharmaceuticalsAtossa Therapeutics, Inc.
Sep 11, 20252025/0281414HIGH DOSE ENDOXIFEN FORMULATIONS AND METHODS OF USEPharmaceuticalsAtossa Therapeutics, Inc.
Aug 14, 20252025/0255838SUSTAINED RELEASE COMPOSITIONS OF ENDOXIFENPharmaceuticalsAtossa Therapeutics, Inc.
Jul 31, 20252025/0241876ANTI-TUMOR COMPOUNDS AND METHODS OF USE THEREOF AND SYNTHESIS THEREOFOrganic fine chemistryAtossa Therapeutics, Inc.
Jul 10, 20252025/0223256METHODS FOR MAKING AND USING ENDOXIFENPharmaceuticalsAtossa Therapeutics, Inc. · patent 12,479,790 granted from it
Feb 27, 20252025/0066286COMPOSITIONS OF (Z)-ENDOXIFEN AND METHODS OF ENRICHMENT THEREOFOrganic fine chemistryAtossa Therapeutics, Inc.
Feb 6, 20252025/0041245ENDOXIFEN FOR TREATMENT OF CANCERSPharmaceuticalsAtossa Therapeutics, Inc.
Dec 26, 20242024/0425443METHODS FOR MAKING AND USING ENDOXIFENPharmaceuticalsAtossa Therapeutics, Inc. · patent 12,275,684 granted from it
Oct 3, 20242024/0327333METHODS FOR MAKING AND USING ENDOXIFENPharmaceuticalsAtossa Therapeutics, Inc. · patent 12,281,056 granted from it
Aug 15, 20242024/0274234REMOTE DETECTION OF PATHOGENSComputer technologyAtossa Therapeutics, Inc.
What it applied for, 2024 to 2025: Pharmaceuticals 10 · Organic fine chemistry 2 · Computer technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ATOS · research, not advice